Gilead Sciences
GILD
#129
Rank
S$194.91 B
Marketcap
S$157.09
Share price
-1.14%
Change (1 day)
28.51%
Change (1 year)

Gilead Sciences (GILD) - Total assets

Total assets on the balance sheet as of September 2025 : S$75.85 Billion

According to Gilead Sciences's latest financial reports the company's total assets are S$75.85 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Gilead Sciences - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$80.19 B-2.26%
2023-12-31S$82.04 B-3.12%
2022-12-31S$84.68 B-7.81%
2021-12-31S$91.86 B1.51%
2020-12-31S$90.49 B8.92%
2019-12-31S$83.08 B-4.49%
2018-12-31S$86.98 B-7.46%
2017-12-31S$94.00 B14%
2016-12-31S$82.46 B12.73%
2015-12-31S$73.15 B59.71%
2014-12-31S$45.80 B60.11%
2013-12-31S$28.60 B10.14%
2012-12-31S$25.97 B15.91%
2011-12-31S$22.40 B50.06%
2010-12-31S$14.93 B9.67%
2009-12-31S$13.61 B37.25%
2008-12-31S$9.92 B18.15%
2007-12-31S$8.39 B34.01%
2006-12-31S$6.26 B-0.09%
2005-12-31S$6.27 B78.29%
2004-12-31S$3.51 B33.15%
2003-12-31S$2.64 B18.18%
2002-12-31S$2.23 B51.92%
2001-12-31S$1.47 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
S$116.81 B 54.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$32.21 B-57.52%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$173.51 B 128.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$8.00 B-89.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$37.84 B-50.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$270.49 B 256.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$249.87 B 229.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$148.94 B 96.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$167.87 B 121.32%๐Ÿ‡บ๐Ÿ‡ธ USA